HawkinsLab.

In partnership with NanoString, we have developed numerous Laboratory Developed Tests (LTD) to improve in the molecular diagnosis and treatment selection for paediatric brain tumour patients. Our tests are clinically validated by a distinguished team of clinicians and scientists, and provide an innovative, efficient, and cost-effective solution to molceular diagnostics.​

 

Clinically Offered: ​

• Sarcoma fusion panel​

• Medulloblastoma subtyping panel​

• Paediatric low-grade glioma panel​

• Ependymoma fusion panel​

• ATRT subtyping panel​

​

In Development:​

• Cellular pathway targeting panel​

• Immune panel for prediction of response to immunotherapy​